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Under  certain  circumstances  cytotoxic T  lymphocytes (CTL) 1 are  induced  by 
processed  antigen (1, 2). The mechanism of processing  is still unknown, but macro- 
phage-like accessory cells (AC) are involved (3-6). The processing presumably allows 
small particles of antigen to form an immunogenic association  with gene products 
coded for by the major histocompatibility complex (MHC). 
One interpretation places the requirement for processed antigen at the level of the 
interaction  between  helper T  cells (Tn)  and  accessory cells. This  interaction would 
generate all the soluble factors (7-10) needed for turning precursor CTL (CTLp) into 
effective  killer  cells.  Since  in  vitro  CTL  can  be  induced  by  soluble  factors  and 
unprocessed antigen alone, i.e., in accessory-cell-depleted cultures (11,  12), cell-to-cell 
contact is deemed to be unnecessary at this step (13-15). The alternative interpretation 
(16)  insists on  the need, in  vivo, for direct contact between antigen-processing cells 
and CTLp.  The experiments to follow were designed to test these alternatives. 
Materials and Methods 
Rats.  AS and HL rats were derived from a breeding nucleus supplied by Dr. P. Gallimore, 
University of Birmingham, England. From this stock, specific pathogen-free lines were devel- 
oped:  offspring delivered by  cesarean  section were  foster nursed  by  specific pathogen-free 
females under barrier maintained conditions. All rats used in this study were specific pathogen 
free. 
Tumors.  The adenovirus 2 transformed lines A2/HLREF/50P/Fa/T2C4  (HL-A2T2)  and 
A2/HLREB/10P/B 1 (HL-B 1  ), derived from H L rats, and A2/ASREB/1 P/F4 (AS-F-4) derived 
from AS, were gifts from Dr. P. Gallimore. (17).  Sp6, a spontaneous tumor isolated from the 
BDX strain (18),  was a  gift from Dr. S. Matzku, Institute for Nuclear Medicine, Heidelberg, 
Federal Republic of Germany. 
Media.  Tumor lines were maintained in RPMI 1640 supplemented with 2 mM glutamine, 
penicillin/streptomycin, 10 mM Hepes, and 5% heat-inactivated fetal calf serum (FCS). Media 
used for nylon wool purification contained  10% FCS and media for chromium release CTL 
assays contained 20% FCS. For the in vitro generation of CTL, Iscove's modified Dulbecco's 
medium (19) plus 10% FCS was used. 
Preparation of Cells.  Spleen and lymph node cell suspensions were prepared by dispersing the 
organs with a Tenbroeck tissue grinder (Technorama AG, Zurich, Switzerland). Thoracic duct 
lymphocytes (TDL) were prepared as previously described (20), with the exception that animals 
were anesthetized with a combination of Hypnorn 0.2 ml/kg (Philips-Duphar N.V., Amster- 
dam, The Netherlands) and Valium 2.5 mg/kg (F. Hoffmann-La Roche, Basel, Switzerland). 
Nylon wool purification of TDL was based on  the method of Julius et  al.  (21)  with the 
modification described previously (20). 
l Abbreviations used in this paper: AC, accessory cells; Con A, concanavalin A; Con A SnF, concanavalin A 
supernatant factor; CTL, cytotoxic T lymphocytes; CTLp, CTL precursors; FCS, fetal calf serum; MHC, 
major histocompatibility  complex; TDL, thoracic duct lymphocytes; Tm T helper lymphoxytes. 
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Generation of CTL  In  Vitro.  In all experiments, except  those  described in Table I  where 
unmanipulated TDL were used, TDL were washed, counted, and incubated on nylon wool 
columns. The nonadherent population was  harvested and cultured at  10 7  responder to  10 6 
tumor stimulator per  20  ml of Iscove's medium or  107  responder to  2  ×  107  lymph node 
stimulator cells. Tumors received 5,000 and lymph nodes 2,000 rad of x irradiation (RT 305, 
300 kV,  10 mA; Phillips X-Ray, Phillips, Holland) before their use as stimulators. To some 
cultures 5% G-100 column purified concanavalin A supernatant factor (Con A SnF) from rat 
spleen cell cultures was added (22). Cultures were incubated for 6 d at 37°C in a humidified 
atmosphere containing 5% CO2, in Coming 25100 tissue culture flasks (Corning Glass Works, 
Coming, NY). 
Cytotoxicity Assay.  After 6 d, which was found to be optimal, cultures were washed twice, the 
cells resuspended in RPMI  1640 and added, at various dilutions in 0.1 ml vol, to Greiner 96 
well v-bottomed microtiter plates together with 5 X  103 ~lchromium-labeled tumor targets or 
Con A blasts. The latter were prepared by incubating lymph node cells at a final concentration 
of 2 ×  106/ml in Iscove's medium containing 5 btg/ml Con A for 2-3 d. Plates were incubated 
at 37°C in a humidified atmosphere containing 5% COz for 4 b, centrifuged, and 50% of the 
volume was harvested and counted. Values reported are the mean specific release of triplicates, 
provided the standard error did not exceed  10% and the specific release was >10%. 
Negative Selection on Adoptive Transfer.  HL/AS F1 rats were sublethally irradiated (600 rad), 
cannulated within 3 d after irradiation, and injected intravenously with 3-10 ×  109 parental 
(AS) TDL. Because the modal transit time from blood to lymph for T  ceils is shorter than for 
B cells (23), the population collected 6-24 h after injection is virtually all T cells (24) of donor 
origin. During the 6-24-h selection period all anti-host reactive T  ceils remain sequestered in 
the irradiated F1 host lymphoid tissue (25). The selected TDL are unreactive to host alloantigens 
in mixed lymphocyte and local graft-vs.-host responses and normal for third-party alloantigens 
(26), 
Negative Selection In Situ.  Normal rats were injected intravenously with 20-100 X  106 HL- 
A2T2 (over this range no differences in response were observed), or 400 X  106 irradiated AS/ 
HL lymph node and spleen cells. These animals were cannulated 24 h later and TDL collected 
for 1 d. 
In some experiments tumor-injected rats  were  placed  in a  restraining cage  and  infused 
through a  tail vein over a  24-h period with Con A SnF containing saline. An equivalent of 
roughly four spleen donors was injected per rat during this time. Control rats received Con A 
SnF in the absence of tumor antigen. 
Results 
Experimental Approach.  AS and HL are two strains of rats which differ at the MHC 
(RT1). In the presence of Con A SnF, normal HL thoracic duct lymphocytes cultured 
in vitro with HL-A2T2 cells, an adenovirus-transformed line of HL origin, give high 
T  cell-mediated (27)  primary CTL responses directed to the tumor-specific antigens 
on HL-A2T2 ceils (unpublished data). These CTL also give high tysis on other HL- 
derived  adenovirus-transformed lines,  e.g.,  HL-B1,  but  only  low  lysis  on  MHC- 
different  AS  adenovirus-transformed cells,  e.g.,  AS-F-4  (Materials  and  Methods). 
These data suggest that the response to the tumor-specific antigens on the transformed 
cells is probably MHC-restricted, although definitive evidence on this point has yet 
to be obtained. 
The experiments considered below were designed to determine whether CTLp for 
HL-A2T2  tumor  ceils  exist  in  an  MHC-different  strain,  i.e.,  in  normal  AS  rats. 
Addressing this  question necessitates  depleting the  responding AS  lymphocytes of 
alloreactivity to HL MHC  determinants. The procedure used here was to  filter AS 
TDL from blood to lymph for  1 d  through irradiated HL/AS F1 rats (Materials and 
Methods). In this system donor cells with alloreactivity to the host are sequestered in 
the  spleen and fail to  enter the  central lymph; recirculation of donor T  cells with DONALD  BELLGRAU  1507 
other specificities is unimpeded. It should be mentioned that B cells recirculate poorly 
in irradiated rats, and the lymph-borne cells consist almost entirely of donor-derived 
T  cells (24). 
In  addition  to  the  above  system,  some  of  the  experiments  considered  below 
employed a  different system in which negative selection was induced in situ, i.e., in 
the donor rat itself. This procedure involves injecting rats with large doses of irradiated 
allogeneic cells and  then collecting the host-derived cells from the central  lymph  1 
day  later  (Materials  and  Methods).  As  in  the  adoptive  transfer  selection  system 
described above, the responding T  cells become selectively sequestered in the spleen 
and are absent  from TDL. By injecting tumor ceils rather than  lymphoid cells this 
system can be used to study negative selection of cells involved in tumor-specific CTL. 
Recognition of Tumor Antigens by MHC-different T Cells.  As shown in Table I, unprimed 
AS TDL incubated for 6 d  in vitro with irradiated MHC-different HL-A2T2 tumor 
cells give high lysis on HL-A2T2 and HL-B1 targets and only low lysis on syngeneic 
AS-F-4 targets (column 1). High lysis is also observed against HL Con A blasts, which 
implies that some of the lysis against the HL-derived tumors is presumably directed 
against HL MHC alloantigens.  Evidence that the HL tumors do indeed express HL 
MHC  determinants  comes  from  the  fact  that  the  tumors  are  lysed  by  AS  TDL 
stimulated with normal HL lymph node cells (column 2). 
Filtration  of AS  TDL  from blood  to  lymph  through  irradiated  AS/HL  Fa  rats 
removes alloreactivity to HL, When  these AS-nL TDL are cultured  with HL-A2T2 
cells, no lysis is observed on HL Con A blasts (Table I, column 3). Significantly, there 
is  high  lysis of HL-A2T2  and  HL-B1  targets.  This  finding  implies  that  AS  TDL 
contain CTLp which are specific for the tumor antigens on MHC-different HL-A2T2 
and HL-B 1 cells. 
In  assessing  the  significance  of these  findings  it  was  conceivable  that  the  CTL 
activity  derived  from  the  AS.nL-fihered  T  cells  (Table  I,  column  3)  reflected  the 
presence of accessory cells.  On a  priori grounds these cells could have been derived 
either from the donor cells or from the irradiated F1 selection host; in either situation 
the accessory cells would be at least semisyngeneic with respect to the responding T 
cells. 
TABLE  I 
Generation of Killer Cells against HL Strain Tumors in tile Absence of T Cells Specific  for HL 
Alloantigens 
Tarot 
Column: 
Responder: 
Stimulator: 
E/T*: 
1  2  3 
AS TDL  AS TDL  AS-HL TDL 
HL-A2T2 tumor  HL lymph node  HL-A2T2 tumor 
50  25  12  50  25  12  50  25  12 
HL-A2T2  39  33  19  36  30  25  42'  32  23 
HL-B1  32  24  19  33  28  24  32  25  16 
AS-F-4  12  7  4  3  1  0  :~  :~  :~ 
HL Con A  32  t7  9  28  25  22  2  2  0 
AS Con A  2  2  0  1  1  0  0  -1  0 
For treatment of responders and stimulators see Materials and Methods. The data are derived from TDL 
from single rats. The animal in column 3 was injected with TDL from three donors. 
* Effector/target cell ratio, 
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TABLE II 
The Requirement  for Radiorest)tant Accessory Cells in the Generation of Anti- 
tumor CTL 
Culture 
additions 
Column: 
Responder: 
Stimulator: 
E/T: 
1  2 
AS nylon-wool-  AS-HL nylon-wool- 
passed TDL  passed TDL 
HL-A2T2 tumor  HL-A2T2-tumor 
50  25  12  50  25  12 
Nil  3  2  2  -2  -1  0 
ACAs  45  44  --  46  44  30 
ACnL  28  22  --  1  2  2 
Con A SnF  35  31  --  42  32  24 
Normal  AS and AS-HL TDL were collected as described  in  Materials  and 
Methods. The nylon wool nonadherent  fractions were cultured with irradiated 
HL-A2T2 tumor. ACAs, ACnL =  2,000 rad-irradiated AS or HL lymph node 
ceils. 
To examine this question, the lymph-borne AS-nL TDL were passed through nylon 
wool  columns  and  then  stimulated  with  HL-A2T2  tumor  cells,  with  or  without 
exogenous  accessory  cells.  T  cells  purified  from  normal  AS  TDL  were  used  as  a 
control. As shown in Table II, T  cells fail to generate CTL activity in the absence of 
accessory  cells.  High  lysis occurs,  however,  if the  cultures  are  supplemented  with 
either  (a)  Con A  SnF or  (b)  syngeneic accessory cells. This  applies with both T  cell 
populations.  With  allogeneic  (HL)  accessory cells, by contrast,  restoration  of CTL 
activity only occurs with normal AS T  ceils and not with AS-HL T  cells. These data 
suggest  that,  in  the  absence  of  alloreactivity,  only  syngeneic  and  not  allogeneic 
accessory cells can initiate the process that leads to tumor-specific CTL. 
Selective  Sequestration  of TH Cells and  CTLp.  The above findings corroborate the 
well-established  finding  that  TH  cells  (or  products  in  Con  A  SnF)  control  CTL 
generation  in  vitro.  Depending  on  the  conditions  used,  help  presumably  reflects 
interleukin production resulting from T  cell contact with either (a) MHC  alloantigens 
(alloreactive AS T  cells confronting  HL  accessory cells;  Table  II, column  1)  or  (b) 
tumor antigens presented on accessory cells. In the case of CTL generated from AS-He 
T  cells, the simplest explanation  for the requirement  for syngeneic accessory cells is 
that  help  reflects MHC-restricted recognition of processed  tumor antigens.  Tumor- 
specific TH  cells recognize  degraded  antigen  on  accessory cells, but  only when  the 
latter are MHC  compatible. 
To seek further information on the role of tumor-specific TH cells, TDL were taken 
from  AS  rats  given  HL-A2T2  tumor  cells intravenously  1  d  before.  Based  on  the 
findings of other workers (28, 29), the expectation here was that accessory cells of the 
host would process the injected tumor cells and  thereby lead to negative selection of 
tumor-specific TH ceils. If CTLp were not selected under these conditions (the above 
references  did  not  address  this  point  directly), TDL  from  these  rats  would contain 
only tumor-specific CTLp and not TH cells. 
The  experiment  shown  in  Table  III,  column  3  suggests  that  injecting  the  TDL 
donors  1 d  previously with  HL-A2T2 tumor cells does indeed remove tumor-specific 
TH cells but  not  CTLp.  When TDL  from  these rats are filtered through  AS/HL  Fx DONALD BELLGRAU 
TABLE III 
Recruitment of Tumor-specific TH but Not CTLp after Injection of Tumor 
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Culture 
additions 
Column:  1  2 
Responder:  AS nylon-wool-passed  AS nylon-woo|-passed 
TDL from HL-A2T2  TDL from HL-A2T2 
tumor-injected donor  tumor-injected donor 
Stimulator:  HL-A2T2 tumor  HL lymph node 
Target:  HL-A2T2  HL Con A 
E/T:  50  25  12  50  25  12 
3 
AS.HL nylon-wool- 
passed TDL from HL- 
A2T2 tumor-injected 
donor HL-A2T2 tumor 
HL-A2T2 
50  25  12 
Nil  0  0  0  15  12  5 
ACAs  -  2  1  22  ll  3 
ACHL  --  41  36  -- 
Con ASnF  32  27  21  15  12  10 
2  0  0 
4  2  1 
2  0  0 
46  32  25 
Culture 
additions 
TABLE IV 
T Cell Activation In  Vivo to Lymphoid Alloantigens 
Colunln: 
Responder: 
Stimulator: 
Target: 
E/T: 
1  2 
AS nylon-wool-passed  TDL from HL lymph- 
oid ceil-injected donor 
HL lymph node  HL-A2T2 tumor 
HL Con A  HL-A2T2 
50  25  12  50  25  12 
Nil  1  1  0  1  1  0 
ACAS  0  0  1  26  22  15 
ACHL  --  1  0  2 
Con A SnF  2  1  0  24  19  7 
rats  to  remove  alloreactivity  and  then  through  nylon  wool  columns  to  remove 
accessory cells, the T  cells fail to generate anti-tumor CTL in vitro in the presence of 
either syngeneic or  allogeneic accessory  cells.  By  contrast,  addition of Con A  SnF 
during culture generates high CTL activity. When TDL from the tumor-injected rats 
are  not  filtered through  AS/HL  F1  rats  before culture, the  addition of allogeneic 
accessory cells restores CTL activity (Table III, column 1);  syngeneic accessory cells 
give no response. The effect observed with the allogeneic accessory cells presumably 
reflects  a  response  (interleukin  production)  to  HL  alloantigens.  In  this  respect, 
culturing the TDL with HL lymph node cells generates appreciable CTL activity on 
HL Con A blasts (column 2). 
Collectively, the  results  in Table  III  suggest  that  preinjecting the  TDL  donors 
selectively removes only tumor-specific Tn cells. There is little or no removal of tumor- 
specific  CTLp,  even  if fivefold higher  doses  of tumor cells  are  injected  (data  not 
shown).  There  is  also  no apparent  removal of either Tn or  CTLp  reactive to  HL 
alloantigens. 
The failure to deplete alloreactivity by injecting tumor cells might be a  reflection 
of the fact that the HL-A2T2 tumor lacks class II (Ia) molecules (30), In this respect 
removal of alloreactive TH and CTLp does occur when the TDL donors are injected, 
not with HL-A2T2 tumor cells, but with large doses of irradiated AS/HL  F1 spleen 1510  INDUCTION  OF  KILLER  T  CELLS  IN  VIVO 
TABLE  V 
Summary of Results 
T  cells tested 
Negative selection of T  cells reactive to: 
HL-A2T2 tumor anti- 
HL alloantigens 
gens 
TH  CTLp  TH  CTLp 
AS cells filtered through irradiated AS/HL F1 rats  + 
AS cells from rats injected  1 d  before with AS/HL F1  + 
lymphoid cells 
AS cells  from rats injected  1 d  before with HL-A2T2  - 
tumor cells 
AS cells  from rats injected  1 d  before with  HL-A2T2  (-)* 
tumor cells plus Con A SnF 
4- 
4- 
--  4- 
+  (+) 
Summary of data from Tables I-IV and Fig. 2. 
* Inferential, not tested directly. 
51  HL  •  anti HL A2T2 
HLA2T2 
-  k% 
30- 
o 
20- 
50  '  25  12  5025  1'2 5b 2'5 ~'2 
E/T 
b 
S  40- 
30- 
2o- 
lo 
AS  •  anti HL A2T2 
ASA2T2 
k  • ~  "--\.  . 
%  • 
5b 2'~ 1'2 ~o2;  1'2 ~b 2'~ 1'2 
E/T 
Fic.  1.  Lack of CTL  recruitment to  tumor antigens  in  syngeneic  and  allogeneic  hosts.  Three 
separate experiments are shown, where nylon-wool-purified TDL from normal rats or rats injected 
24 h  earlier with HL-A2T2 tumor are cultured with HL-A2T2 in the presence of Con A SnF. The 
specific chromium release in the control populations was always <7%. 
plus  LN cells  (50%  Ia  +)  1 d  before  (Table  IV).  When  nylon-wool-passed  TDL from 
these  rats  are  cultured  with  HL  lymph  node cells  in  vitro,  no CTL  for  HL  Con  A 
blasts  are  generated  even  in  the presence  of Con A  SnF  (column  1).  The TDL  thus 
lacked  allospecific  CTLp.  When  the TDL  are cultured  with  HL-A2T2  tumor  cells, 
anti-tumor  CTL activity  is generated,  but only in the presence of syngeneic  and not 
allogeneic  accessory cells.  This latter finding implies that the TDL lacked allospecific 
T~ cells  (cells able to provide nonspecific  help in response to HL alloantigens).  These 
data are summarized  in Table V. 
With  respect  to  anti-tumor  CTL,  it  is  to  be  noted  that  addition  of syngeneic 
accessory  cells  does  restore  the  capacity  of TDL  from  F1  spleen-injected  AS  rats  to 
generate  CTL  to  HL-A2T2  cells  (Table  IV,  column  2).  This  is  the  same  result 
observed  in  Table  II,  column  2,  i.e.,  where  the  T  cells  were  also  depleted  of 
alloreactivity  to HL,  but by in vivo filtration. 
Requirements for Inducing Negative Selection of CTLp: Evidence of Two Signals.  The fact 
that  injecting AS rats with large doses of HL-A2T2  tumor cells  fails to remove either 
tumor-specific  or allospecific  CTLp  is surprising,  particularly  since  even small  doses 
of tumor cells  remove tumor-specific  TH cells.  In the case of tumor-specific  CTLp,  it 
seemed possible that  the MHC  barrier between  the injected  tumor cells  and the host 
might  somehow  have  impeded  selection.  The  experiment  shown  in  Fig.  1 rules  out 
this possibility.  Here it is shown that no selection of tumor-specific  CTLp occurs even DONALD  BELLGRAU  1511 
40- 
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20" 
10- 
'  J  i  r  i 
-~  • 
i  i  i 
C  50- 
40- 
30- 
20- 
10- 
© 
AS 
ASHL-A2T2 
AScon ASnF 
AS HL-A2T2,  Con ASnF 
lb  2b  3b  ab  sb 
E/T 
Fic.  2.  Activation  of anti-tumor CTL  in Con  A  SnF-transferred animals.  Nylon-wool-purified 
TDL were (a) cultured and tested on HL-A2T2 tumor, (b) cultured with ACBDx (allogeneic and 
MHC incompatible to both HL and AS), and tested on Sp6, a  BDX spontaneous tumor. Con A 
SnF was added to all flasks at the initiation of the culture period. 
when HL-A2T2 tumor cells are injected into MHC-compatible HL rats. 
The experiment shown in Fig. 2 was designed to examine the notion that CTLp in 
vivo may recognize tumor antigens (receive signal 1) but are not selected (sequestered) 
because  they  fail  to  receive  a  second  signal.  To  test  this  prediction  AS  rats  were 
injected with tumor ceils and then perfused with Con A  SnF, a  presumed source of 
the second signal. Control rats were untreated,  treated with tumor alone, or treated 
with Con A  SnF alone. The results (Fig. 2) show a pronounced reduction in anti-HL 
A2T2 tumor (Fig. 2 a) and anti-HL (Fig. 2 b) activity in the group that received both 
tumor cells and Con A  SnF. The control groups, given tumor or Con A  SnF alone, 
did  not  differ  from  the  untreated  controls.  The  four  groups  showed  equivalent 
reactivity  against  a  third  party  alloantigen  (Fig.  2c),  indicating  that  retention  of 
CTLp was specific for the  injected  antigen.  A  single experiment with  concomitant 
injection of HL lymphoid and tumor cells revealed that tumor specific CTLp were 
not retained unless Con A SnF was also supplied. 
Discussion 
The  results  in  this  paper  demonstrate  that,  in  the  absence  of  alloreactivity, 
activation  of  killer  ceils  against  allogeneic  tumor  antigens  in  vitro  requires  the 
cooperation of tumor-specific helper T  ceils.  Stimulation  of the helper ceils requires 1512  INDUCTION OF  KILLER T  CELLS IN VIVO 
syngeneic accessory cells;  these cells presumably "process" the  tumor antigens  and 
present  them in association with self MHC  determinants.  Recognition of processed 
antigen is important only for TH cells and not CTLp. Once the helper cell-accessory 
cell interaction has taken place, a  variety of soluble factors is released and these are 
sufficient to induce the CTLp-CTL transition. 
According to the above scheme, the activation and differentiation of CTLp requires 
two signals:  (a)  recognition of antigen on the tumor cells by CTLp and  (b) a  signal 
provided  by  TH  cells.  Whether  these  signals  must  be  received  simultaneously  is 
difficult  to study in vitro since CTL are measured only after a  period of 6  d. A  key 
question is whether CTLp can recognize antigen in the absence of the second signal. 
A  useful  approach  to  this  question  is  to  examine  the  requirements  for producing 
negative selection ofT cells in vivo--a phenomenon that occurs within  1 d of contact 
with antigen.  Since negative selection is manifested by a  withdrawal  of T  cells from 
the  recirculating  lymphocyte  pool,  one  might  conclude  that  selection  is  simply  a 
reflection  of antigen  binding  by the  responding  T  cells.  If this  were  the  case,  the 
selection  of CTLp would  require  only one signal.  Alternatively,  selection of CTLp 
might reflect T  cell activation and thus require a second signal. 
The experiments in this paper suggest that selection of CTLp does indeed require 
two signals. Little or no selection of either tumor-specific or allospecific CTLp occurs 
when the T  cells are exposed to these antigens on tumor cells in vivo in the absence 
of Con A  SnF.  In the presence of Con A  SnF, by contrast, effective selection occurs. 
In  interpreting  these  findings  two  points  should  be  emphasized.  First,  the  precise 
effects of Con A  SnF in promoting negative selection of CTLp are not clear. Con A 
SnF is known to contain a variety of lymphokines, including interleukins  1 and 2 (9) 
and a  cytotoxic T  lymphocyte differentiation factor (10).  Any or all of these factors 
might  control  negative  selection.  Secondly,  in  contrast  to  tumor cells,  injection  of 
allogeneic lymphoid cells does select allospecific CTLp in the absence of Con A  SnF 
(Table IV). Although this requirement for Ia  + cells as the targets for negative selection 
has yet to be proved, one could envisage that these cells simultaneously attract both 
TH  cells  and  CTLp,  with  the  result  that  the  CTLp  are  exposed  to  a  high  local 
concentration of helper factors (signal 2). Alternatively, the Ia  + cells themselves might 
release factors which facilitate recognition of antigen by the CTLp. 
The model of CTL activation developed in this study fits also several observations 
that were difficult to reconcile with data provided by in vitro experiments. Zinkernagel 
et al.  (31)  and yon Boehmer and Haas (32)  demonstrated a  requirement for I region 
sharing in the generation of CTL in vivo. Keene and Forman  (33)  showed that  for 
effective priming to occur in vivo helper determinants required for expression of CTL 
activity must be on the same cell as the CTL determinants. Korngold and Sprent (34) 
reported that the induction of graft-vs.-host disease requires contact with antigen on 
marrow-derived  (AC?)  cells,  whereas  the  effector cells were targeted  to  Ia negative 
non-marrow-derived cells. In each case the immunogenicity of a  target antigen for a 
K,D-restricted CTL would  appear to controlled  by the  I  region.  These data are in 
apparent  disagreement with  a  study of Doherty and  Bennink  (35),  who concluded 
that  virus-specific CTL  can  be  activated  to  antigen  in  Ia-incompatible irradiated 
mice. These authors  used an in  vivo filtration system to remove alloreactive T  cells 
but  did  not  attempt  to  remove accessory cells  from the  filtered  T  cell  population. 
Hence carry-over of accessory cells might explain their results (Table II and reference DONALD BELLGRAU  1513 
36). 
Finally,  comment should  be  made on  the  following paradox.  It  was  mentioned 
earlier (Results)  that primary responses to syngeneic adenovirus-transformed tumors 
are low unless the cultures are supplemented with Con A  SnF. This finding implies 
that  unprimed  rats  are relatively deficient  in  tumor-specific T~ cells.  In allogeneic 
situations, by contrast, high primary antitumor responses are observed in the absence 
of Con A SnF (Table II); the response occurs in the apparent absence of alloreactive 
T  cells  and requires syngeneic accessory cells.  In the light of this finding, one reaches 
the surprising conclusion that  the precursor frequency of tumor-specific TH cells  is 
much higher when  the  antigens  are  derived  from  MHC-incompatible tumor cells. 
Possible explanations for this unexpected finding are discussed elsewherefl 
Summary 
Strain  AS  rats  respond  with  two  populations  of cytotoxic  T  lymphocytes  to 
stimulation  in vitro by the major histocompatibility complex  (MHC)-incompatible 
strain  HL rat  tumor  (HL-A2T2). One is specific for MHC alloantigens present  on 
both HL-A2T2 and normal HL targets, the other is tumor specific. The activation of 
these killer cells requires helper T lymphocytes. The tumor-specific helper cells depend 
on  syngeneic  radioresistant  accessory  cells  to  present  the  tumor  antigens  in  an 
immunogenic form. The appropriate helper-accessory cell  interaction  results  in  the 
production of soluble factors which then induce the maturation of precursor cells into 
effective killer cells. 
Studies with a  procedure for inducing negative selection of T  cells  in vivo showed 
that  short-term exposure to  HL-A2T2 tumor induced selection only of TH but  not 
cytotoxic T  lymphocyte precursors  (CTLp).  Simultaneous injection of supernatants 
from concanavalin A-activated spleen cell cultures, however, did produce selection of 
CTLp. These and other findings suggest that  under normal circumstances in  vivo, 
both  signals  (recognition  of  antigen  and  acceptance  of  maturation  factors)  are 
provided in the vicinity of an antigen presenting macrophage-like accessory cell. 
I wish to thank Dr. P. Gallimore for kindly supplying the adenovirus  transformed  tumor lines 
and  the  original  rat  strains  from  which  they were  derived.  I  am  grateful  to  Drs. H.  yon 
Boehmer,  M. Julius, and S. Fazekas de St. Groth for helping  me write the manuscript.  The 
technical  assistance of Beatrice Dolder is gratefully  acknowledged. 
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